B

Bausch Lomb

Makes eye medicines, lenses and surgical devices

National Accounts Director; Payor Accounts

Full-TimeUpdated on 10/15/2026
$220k - $255k+ Short-term and/or long-term incentives
Senior
Bachelor's, Master's
Remote in USA
RemoteTravel required 25–50%.
Sales & Account ManagementAccount Management
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in public health or life science is required; a graduate degree and ophthalmology experience are preferred.
  • Five to seven years of payor relations experience with Medicare and private insurance at the national and/or regional level, strong knowledge of medical device reimbursement and CPT coding, and a proven track record securing positive payor coverage and reimbursement for medical devices.
  • Demonstrated success securing coverage for new and emerging technologies and influencing payor coverage policies.
  • Strong understanding of clinical and economic data, coding, coverage, and payment issues, and ability to communicate them.
  • Comprehensive understanding of the current and evolving payor ophthalmology management landscape, including MIGS and cataract perspectives.
  • Strong customer business planning, tactical planning, working with ambiguity, and execution skills.
  • Ability to drive consensus and demonstrate leadership, communication, and collaboration skills.
  • Strong understanding of reimbursement principles across physician offices, ambulatory surgery centers, and hospital outpatient departments.
  • Strong written and presentation skills for internal and external executive management.
  • Proficiency in Microsoft PowerPoint, Excel, and Word.
  • Ability to travel 25–50%.
  • Authorization to work for any U.S. employer is required; employment visa sponsorship is not available.
Responsibilities
  • Develop and execute national and regional payor coverage and reimbursement strategies to secure coverage and appropriate reimbursement, commercial viability, and patient access to the Elios System based on clinical data, health economics and outcomes research (HEOR) data, and value propositions.
  • Engage health technology assessment firms to provide current reviews of excimer laser trabeculostomy and Elios System clinical data, and provide education and materials supporting positive conclusions from peer-reviewed clinical literature.
  • Develop and maintain relationships with target payors and working knowledge of their processes, including medical policy, utilization review, per-member-per-month thresholds, health outcomes, risk management, provider contracting, and claims processing.
  • Develop relationships with state-level Ophthalmology Advisory Committee members and payor Medical Directors for public and private payors to support changes reflecting local medical practices.
  • Use the PRC-approved payor presentation and published literature, along with the budget impact model demonstrating the Elios System’s value, to influence coverage policy development.
  • Monitor Medicare fee-for-service, Medicare Advantage, and commercial payor coverage policies; track review periods; and analyze medical review, prior authorization, and claims payment trends to inform payor strategy, tactics, and team priorities.
  • Collaborate with Field Sales Managers on key accounts as needed to ensure coverage, coding, and payment requirements are understood and support pull-through efforts.
  • Work with Medical Affairs to support clinical education with key local key opinion leaders to influence payor coverage and medical review policies.
  • Improve the effectiveness and focus of industry alliances, such as MDMA and OOSS, as needed to support Medicare and commercial payor policy and patient access.
  • Provide internal and external voice-of-customer feedback to guide strategy development.
  • Assist the Head of Market Access in ensuring Medicare Administrative Contractors provide appropriate coverage and payment for ELIOS across the Medicare Physician Fee Schedule, ambulatory surgery centers, and hospital outpatient departments.
  • Assist in developing market access programs to train Sales Representatives.
  • Lead a team of Regional Account Executives to position the Elios System with payors, integrated delivery networks, and key hospitals to maximize patient access and organizational revenue.
  • Partner cross-functionally with sales, marketing, and medical/clinical affairs teams to inform the HEOR strategy needed to obtain and maintain optimal U.S. coverage and reimbursement.
Desired Qualifications
  • A graduate degree and ophthalmology experience are preferred.

About the company

Bausch + Lomb develops and sells eye-health products for patients, consumers and clinicians, spanning everyday vision correction, prescription treatment and eye surgery. Its portfolio combines contact lenses and lens-care solutions with medicines for eye conditions and equipment used in cataract, retinal and refractive procedures. The company also sells surgical consumables and implanted lenses, supplying products used both at home and in clinical settings. It earns revenue through product sales across its vision care, pharmaceuticals and surgical businesses. Founded as an optical goods store in Rochester in 1853, Bausch + Lomb is headquartered in Vaughan, Ontario, with its U.S. headquarters in Bridgewater, New Jersey.

Company Size

10,001+

Company Stage

N/A

Total Funding

N/A

Headquarters

Vaughan, Canada

Founded

1853

Get referred to Bausch Lomb

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Sales are growing: Bausch + Lomb's July 2026 results show second-quarter revenue rose 9% to $1.394 billion.
  • Eligible U.S. staff have tuition support: September 2026's Bausch + Lomb Boston ad lists reimbursement for select degrees.
  • Retinal research has another candidate: October 2026's announcement plans 2027 clinical development of Bausch + Lomb's oral tonabersat.

What critics are saying

  • Leadership is interim: Bausch + Lomb appointed Thomas Appio and announced Brent Saunders' departure in October 2026.
  • Shareholders still face losses: Bausch + Lomb reported a $14 million attributable second-quarter loss in July 2026.
  • Remote means field travel: Bausch + Lomb's Boston role requires 25-50% travel, including overnights, in September 2026's posting.

What makes Bausch Lomb unique

  • Bausch Health retains control: it held approximately 87% of Bausch + Lomb shares in July 2026.
  • A prescription targets tear evaporation: Bausch + Lomb's MIEBO dry-eye drops act directly on excess tear loss.
  • Lens waste has a collection route: Bausch + Lomb's U.S. ONE by ONE program accepts lenses and blister packs.

Help us improve and share your feedback! Did you find this helpful?